Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 9 » Issue 1

Distinguishing adult-onset asthma from COPD: a review and a new approach

Authors Abramson MJ, Perret JL, Dharmage SC, McDonald VM, McDonald CF

Received 21 March 2014

Accepted for publication 27 May 2014

Published 9 September 2014 Volume 2014:9(1) Pages 945—962

DOI https://doi.org/10.2147/COPD.S46761

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Michael J Abramson,1 Jennifer L Perret,2,3 Shyamali C Dharmage,2 Vanessa M McDonald,4 Christine F McDonald3

1School of Public Health and Preventive Medicine, Monash University, 2Centre for Epidemiology and Biostatistics, University of Melbourne, Melbourne, Australia; 3Department of Respiratory and Sleep Medicine, Austin Health, Heidelberg, Australia; 4Priority Research Centre for Asthma and Respiratory Disease, University of Newcastle, Newcastle, Australia

Abstract: Adult-onset asthma and chronic obstructive pulmonary disease (COPD) are major public health burdens. This review presents a comprehensive synopsis of their epidemiology, pathophysiology, and clinical presentations; describes how they can be distinguished; and considers both established and proposed new approaches to their management. Both adult-onset asthma and COPD are complex diseases arising from gene–environment interactions. Early life exposures such as childhood infections, smoke, obesity, and allergy influence adult-onset asthma. While the established environmental risk factors for COPD are adult tobacco and biomass smoke, there is emerging evidence that some childhood exposures such as maternal smoking and infections may cause COPD. Asthma has been characterized predominantly by Type 2 helper T cell (Th2) cytokine-mediated eosinophilic airway inflammation associated with airway hyperresponsiveness. In established COPD, the inflammatory cell infiltrate in small airways comprises predominantly neutrophils and cytotoxic T cells (CD8 positive lymphocytes). Parenchymal destruction (emphysema) in COPD is associated with loss of lung tissue elasticity, and small airways collapse during exhalation. The precise definition of chronic airflow limitation is affected by age; a fixed cut-off of forced expiratory volume in 1 second/forced vital capacity leads to overdiagnosis of COPD in the elderly. Traditional approaches to distinguishing between asthma and COPD have highlighted age of onset, variability of symptoms, reversibility of airflow limitation, and atopy. Each of these is associated with error due to overlap and convergence of clinical characteristics. The management of chronic stable asthma and COPD is similarly convergent. New approaches to the management of obstructive airway diseases in adults have been proposed based on inflammometry and also multidimensional assessment, which focuses on the four domains of the airways, comorbidity, self-management, and risk factors. Short-acting beta-agonists provide effective symptom relief in airway diseases. Inhalers combining a long-acting beta-agonist and corticosteroid are now widely used for both asthma and COPD. Written action plans are a cornerstone of asthma management although evidence for self-management in COPD is less compelling. The current management of chronic asthma in adults is based on achieving and maintaining control through step-up and step-down approaches, but further trials of back-titration in COPD are required before a similar approach can be endorsed. Long-acting inhaled anticholinergic medications are particularly useful in COPD. Other distinctive features of management include pulmonary rehabilitation, home oxygen, and end of life care.

Keywords: chronic obstructive pulmonary disease, diagnosis, management, adults, inflammometry

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Symptoms and lung function decline in a middle-aged cohort of males and females in Australia

Abramson MJ, Kaushik S, Benke GP, Borg BM, Smith CL, Dharmage SC, Thompson BR

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:1097-1103

Published Date: 26 May 2016

Readers of this article also read:

The stats are in: an update on statin use in COPD

Carlson AA, Smith EA, Reid DJ

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2277-2284

Published Date: 22 October 2015

Enhanced antidepressant-like effects of the macromolecule trefoil factor 3 by loading into negatively charged liposomes

Qin J, Yang X, Mi J, Wang J, Hou J, Shen T, Li Y, Wang B, Li X, Zhu W

International Journal of Nanomedicine 2014, 9:5247-5257

Published Date: 12 November 2014